Hans-Martin Blickensdoerfer - 07 Sep 2021 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role: Sr. VP, Comm. Ops, China
Signature: /s/ Samuel Gesten as attorney-in-fact for Hans Blickensdoerfer
Issuer symbol: STAA
Transactions as of: 07 Sep 2021
Net transactions value: -$5,478,244
Form type: 4
Filing time: 09 Sep 2021, 16:03:07 UTC
Previous filing: 03 Sep 2021
Next filing: 08 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STAA	Common Stock	Sale	$1,813,563	-11,522	-13%	$157.40	77,200	07 Sep 2021	Direct	F1
transaction	STAA	Common Stock	Options Exercise	$504,835	+14,031	+18%	$35.98	91,231	07 Sep 2021	Direct
transaction	STAA	Common Stock	Options Exercise	$415,703	+15,100	+17%	$27.53	106,331	07 Sep 2021	Direct
transaction	STAA	Common Stock	Sale	$4,585,219	-29,131	-27%	$157.40	77,200	07 Sep 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STAA	Common Stock Options	Options Exercise	$0	-14,031	-77%	$0.000000	4,109	07 Sep 2021	Common Stock	14,031	$35.98	Direct	F3
transaction	STAA	Common Stock Options	Options Exercise	$0	-15,100	-47%	$0.000000	16,879	07 Sep 2021	Common Stock	15,100	$27.53	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.45, inclusive.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.46, inclusive.
F3	The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029.
F4	The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the next 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.